MiniMed 630G System

The MiniMed 630G insulin pump system

MiniMed 630G


The MiniMed 630G insulin pump closely mimics the way a healthy pancreas delivers basal insulin to your body. Precise insulin delivery helps you achieve your ideal A1C and reduces the risk of highs without increasing lows3,4.

Blood Glucose meter for added convenience

The Ascencia CONTOUR® NEXT LINK 2.4 blood glucose meter sends glucose readings wirelessly to your MiniMed 630G insulin pump, saving you time and effort, as well as eliminating manual data entry errors. LEARN MORE

An Infusion Set for Every Body

Our infusion sets with the patented MiniMed connection are designed to provide a secure insulin delivery from your insulin pump to your body. We offer a wide portfolio of different infusion sets to meet your lifestyle needs and body type. LEARN MORE

Data Management tools

Medtronic CareLink® Personal Software is a convenient online tool that helps you accurately tracks your insulin usage and glucose levels, allowing you to compare any changes in glucose levels with your daily activities, such as meals and exercise routines. Clear charts and graphs show you these changes and help you and your healthcare provider discover patterns and adjust your therapy for better control. LEARN MORE

Continous Glucose Monitoring

Continuous Glucose Monitoring (CGM) technology tracks glucose levels in your body 24 hours a day. CGM uses a sensor that connects through wireless frequency to your MiniMed insulin pump- giving you early warnings of highs and lows. CGM is clinically proven to lower A1c levels and reduce hypoglycemia1,2,5LEARN MORE



  • 1 Bergenstal RM, Tamborlane WV, Ahmann A, et al. The STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-320
  • 2 Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of Type 1 diabetes. N Engl J Med. 2008;359:1464-1476.
  • 3 The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
  • 4 The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643-2653.Bergenstal RM, Klono_ DC, Garg SK. E t al. N Engl J Med. June 22, 2013DOI: 10.1056 / NEJMoa1303576
  • 5 Battelino T et al. The SWITCH Study. Pediatric Diabetes 2011 Diabetologia DOI 10.1007/s00125-012-2708-9 Epub ahead of print and Aspire In-Home